Welcome back to the start of the school year! I hope you all had a wonderful summer break. Let’s settle down and take our seats, shall we?

Class …seats, please. Don’t make me ask again. Amgen, Regeneron, are you two arguing already? I’m going to have you sit on opposite sides of the classroom if you can’t get along. Alexion, I know the map of Brazil is fascinating, but please find a seat. Don’t make me threaten you with detention. Yes, Gilead, of course you can sit in the front row.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy